Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Protein Design Labs' humanized antibody effective in reducing kidney transplant rejection

Oct. 4, 1996

First approval for a DTaP-IPV vaccine

Oct. 4, 1996

PPL Therapeutics-RPMS xenotransplantation collaboration

Oct. 4, 1996

delta-Opioid antagonists for non-CNS applications

Oct. 4, 1996

Fournier investigates deoxyspergualin analogues

Oct. 4, 1996

Promising phase II results with vaccine for staph infections

Sep. 27, 1996

Clinical trial of an oral Campylobacter vaccine and adjuvant combination

Sep. 27, 1996

Immunosuppressant oligopeptide from Italfarmaco

Sep. 27, 1996

Kureha glycoproteins show antitumor and immunomodulatory effects

Sep. 27, 1996

New introduction for Prograf

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.